Ferozsons Laboratories : Financial Results for the Quarter Ended 2022-09-30

Ferozsons Laboratories Limite

Condensed Interim Unconsolidated Statement of Profit or Loss (Un-audited)

For the period ended 30 September 2022

	First Quarter ended
	30 September	30 September
	2022	2021
	---------------------- Rupees -----------------
Revenue - net	2,286,494,656	1,693,186,215
Cost of sales	(1,292,816,834)	(866,753,209)
Gross profit	993,677,822	826,433,006
Administrative expenses	(152,262,244)	(121,844,633)
Selling and distribution expenses	(560,879,547)	(429,967,799)
Other expenses	(147,687,629)	(97,614,705)
Other income	44,622,436	46,052,929
Profit from operations	177,470,838	223,058,798
Finance cost	(20,377,337)	(3,841,214)
Profit before taxation	157,093,501	219,217,584
Taxation	(52,175,930)	(58,817,631)
Profit after taxation	104,917,571	160,399,953
Earnings per share - basic and diluted		Re-stated
2.41	3.69

Ferozsons Laboratories Limited

Condensed Interim Consolidated Statement of Profit or Loss (Un-audited)

For the period ended 30 September 2022

	First Quarter ended
	30 September		30 September
	2022	2021
	---------------------- Rupees ----------------------
Revenue - net	2,566,996,821	2,223,282,284
Cost of sales	(1,489,924,570)	(1,198,797,940)
Gross profit	1,077,072,251		1,024,484,344
Administrative expenses	(171,584,475)	(136,219,020)
Selling and distribution expenses	(611,189,254)	(462,665,538)
Other expenses	(144,245,078)	(108,494,121)
Other income	74,642,779	90,751,221
Profit from operations	224,696,223		407,856,886
Finance cost	(34,670,058)	(27,192,799)
Profit before taxation	190,026,165		380,664,087
Taxation	(57,831,868)	(79,674,096)
Profit after taxation	132,194,297		300,989,991
Attributable to:
Owners of the Group	126,334,743	273,431,879
Non-controlling interests	5,859,554	27,558,112
Profit after taxation	132,194,297		300,989,991
Earnings per share - basic and diluted	2.91		Re-stated
6.29